DNA Link, COVID-19 (Diagnostic Kit) Theme Rises 8.14% Amid Uptrend
On the 6th, the COVID-19 (diagnostic kit) theme rose by 3.47% compared to the previous day, showing strength, while DNA Link, which is attracting attention as a related stock, surged by 8.14% compared to the previous day. DNA Link is known as a genome analysis specialized venture company.
[Graph] Major stock price changes in the COVID-19 (diagnostic kit) theme

According to the analysis by Thinkpool Robo Algorithm RASSI, DNA Link’s quant financial score is 3.76 points, which is lower in stability, profitability, and growth scores compared to the average of other stocks related to COVID-19 (diagnostic kits). This can be interpreted as DNA Link having relatively low investment attractiveness compared to other stocks from a financial perspective. On the other hand, Huons ranked first in quant financial ranking with higher growth, stability, and profitability scores compared to the average of other stocks.
[Table] Top stocks by financial score within the theme

Hot Picks Today
"Now Our Salaries Are 10 Million Won a Month" Record High... Semiconductor Boom Drives Performance Bonuses at Major Electronic Component Firms
- Experts Already Watching Closely..."Target Price Set at 970,000 Won" Only Upward Momentum Remains [Weekend Money]
- "Heading for 2 Million Won": The Company the Securities Industry Says Not to Doubt [Weekend Money]
- 'Still Hesitant? If You're Wondering Whether KOSPI Will Rise, This Is the Number You Must Watch [Weekend Money]'
- Is It Really Like an Illness? "I Can't Wait to Go Again"—Over 1 Million Visited in Q1, Now 'Busanbyeong' Takes Hold [K-Holic]
※ The quant financial score is the result of the Robo Algorithm’s analysis based on each company’s sales growth rate, equity growth rate, debt ratio, current ratio, ROA, ROE, etc.
※ This article was generated in real-time by an article automatic generation algorithm jointly developed by Asia Economy and the financial AI specialized company Thinkpool.
© The Asia Business Daily(www.asiae.co.kr). All rights reserved.